Int J Stomatol

Inter J Stomatol ›› 2018, Vol. 45 ›› Issue (3): 335-339.doi: 10.7518/gjkq.2018.03.017

• Reviews • Previous Articles     Next Articles

Correlation between periodontal diseases and Alzheimer’s disease

Li Yihan, Pan Lanlan   

  1. School of Stomatology, Chongqing Medical University, Dept. of Periodontology, Stomatological Hospital, Chongqing Medical University, Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing 401147, China
  • Received:2017-07-12 Revised:2018-01-29 Published:2018-05-08
  • Supported by:
    This study was supported by Chongqing Medical Research Project (2015MSXM050).

RichHTML

25

PDF (PC)

738

Abstract: Alzheimer’s disease (AD) is a chronic, progressive and irreversible neurodegenerative disease. The prevalence of AD increases exponentially with age. Although the pathophysiologic mechanism is not fully understood, inflammation has been confirmedto play a critical role in the pathogenesis of AD. Chronic periodontitisis a chronic immuno-inflammatory disease initiated by complex polymicrobial subgingival biofilm. Periodontal pathogens are implicated in the development of a number of inflammatory pathologies at remote organ sites, including brain tissue where AD occurs. The objective of this review is to present the relationship and possible mechanistic links between periodontal disease and AD.

Key words: Alzheimer’s disease;, periodontitis, periodontal pathogen, cytokines, immune response

CLC Number: 

  • R781.4

TrendMD: 
[1] Olsen I, Singhrao SK.Can oral infection be a risk factor for Alzheimer’s disease[J]. J Oral Microbiol, 2015, 7:29143.
[2] Martande SS, Pradeep AR, Singh SP, et al.Periodontal health condition in patients with Alzheimer’s disease[J]. Am J Alzheimers Dis Other Demen, 2014, 29(6): 498-502.
[3] Wu Z, Nakanishi H.Connection between periodontitis and Alzheimer’s disease: possible roles of microglia and leptomeningeal cells[J]. J Pharmacol Sci, 2014, 126(1):8-13.
[4] Genco RJ.Current view of risk factors for periodontal diseases[J]. J Periodontol, 1996, 67(10 Suppl):1041-1049.
[5] Gamboa F, Acosta A, García DA, et al.Occurrence of Porphyromonas gingivalis and its antibacterial susceptibility to metronidazole and tetracycline in patients with chronic periodontitis[J]. Acta Odontol Latinoam, 2014, 27(3):137-144.
[6] Hussain M, Stover CM, Dupont A.P. gingivalis in periodontal disease and atherosclerosis-scenes of action for antimicrobial peptides and complement[J]. Front Immunol, 2015, 6:45.
[7] Kamer AR, Craig RG, Dasanayake AP, et al.Inflam-mation and Alzheimer’s disease: possible role of periodontal diseases[J]. Alzheimers Dement, 2008, 4(4):242-250.
[8] Uppoor AS, Lohi HS, Nayak D.Periodontitis and Alzheimer’s disease: oral systemic link still on the rise[J]. Gerodontology, 2013, 30(3):239-242.
[9] Noble JM, Borrell LN, Papapanou PN, et al.Perio-dontitis is associated with cognitive impairment among older adults: analysis of NHANES-Ⅲ[J]. J Neurol Neurosurg Psychiatry, 2009, 80(11):1206-1211.
[10] Sparks Stein P, Steffen MJ, Smith C, et al.Serum antibodies to periodontal pathogens are a risk factor for Alzheimer’s disease[J]. Alzheimers Dement, 2012, 8(3):196-203.
[11] Poole S, Singhrao SK, Kesavalu L, et al.Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue[J]. J Alzheimers Dis, 2013, 36(4):665-677.
[12] Riviere GR, Riviere KH, Smith KS.Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer’s disease[J]. Oral Microbiol Immunol, 2002, 17(2): 113-118.
[13] Noble JM, Scarmeas N, Celenti RS, et al.Serum IgG antibody levels to periodontal microbiota are asso-ciated with incident Alzheimer disease[J]. PLoS One, 2014, 9(12):e114959.
[14] Grammas P, Ovase R.Inflammatory factors are ele-vated in brain microvessels in Alzheimer’s disease[J]. Neurobiol Aging, 2001, 22(6):837-842.
[15] van Exel E, Eikelenboom P, Comijs H, et al. Va-scular factors and markers of inflammation in off-spring with a parental history of late-onset Alzheimer disease[J]. Arch Gen Psychiatry, 2009, 66(11):1263-1270.
[16] Kamer AR, Craig RG, Pirraglia E, et al.TNF-α and antibodies to periodontal bacteria discriminate be-tween Alzheimer’s disease patients and normal sub-jects[J]. J Neuroimmunol, 2009, 216(1/2):92-97.
[17] Loos BG.Systemic markers of inflammation in perio-dontitis[J]. J Periodontol, 2005, 76(11 Suppl):2106-2115.
[18] Bretz WA, Weyant RJ, Corby PM, et al.Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population[J]. J Am Geriatr Soc, 2005, 53(9):1532-1537.
[19] Kook SY, Seok Hong H, Moon M, et al.Disruption of blood-brain barrier in Alzheimer disease patho-genesis[J]. Tissue Barriers, 2013, 1(2):e23993.
[20] Banks WA, Farr SA, Morley JE.Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes[J]. Neuroimmunomodulation, 2002, 10(6):319-327.
[21] McGeer PL, Rogers J, McGeer EG. Neuroimmune mechanisms in Alzheimer disease pathogenesis[J]. Alzheimer Dis Assoc Disord, 1994, 8(3):149-158.
[22] Grammas P, Ovase R.Inflammatory factors are ele-vated in brain microvessels in Alzheimer’s disease[J]. Neurobiol Aging, 2001, 22(6):837-842.
[23] Akiyama H, Barger S, Barnum S, et al.Inflammation and Alzheimer’s disease[J]. Neurobiol Aging, 2000, 21(3):383-421.
[24] McGeer PL, McGeer EG. Inflammation, autotoxicity and Alzheimer disease[J]. Neurobiol Aging, 2001, 22(6):799-809.
[25] Konsman JP, Drukarch B, Van Dam AM.(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology[J]. Clin Sci, 2007, 112(1):1-25.
[26] Gosselin D, Rivest S.Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system[J]. Brain Behav Immun, 2007, 21(3):281-289.
[27] Engelhart MJ, Geerlings MI, Meijer J, et al.Inflam-matory proteins in plasma and the risk of dementia: the rotterdam study[J]. Arch Neurol, 2004, 61(5): 668-672.
[28] Yaffe K, Kanaya A, Lindquist K, et al.The meta- bolic syndrome, inflammation, and risk of cognitive decline[J]. JAMA, 2004, 292(18):2237-2242.
[29] Schmidt R, Schmidt H, Curb JD, et al.Early inflam-mation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study[J]. Ann Neurol, 2002, 52(2):168-174.
[30] Kálmán J, Juhász A, Laird G, et al.Serum interleu-kin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer’s disease[J]. Acta Neurol Scand, 1997, 96(4):236-240.
[31] Holmes C, El-Okl M, Williams AL, et al.Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer’s disease[J]. J Neurol Neurosurg Psychiatry, 2003, 74(6):788-789.
[32] Nicoll JA, Mrak RE, Graham DI, et al.Association of interleukin-1 gene polymorphisms with Alzheimer’s disease[J]. Ann Neurol, 2000, 47(3):365-368.
[33] Kinane DF, Marshall GJ.Periodontal manifestations of systemic disease[J]. Aust Dent J, 2001, 46(1):2-12.
[34] Forner L, Larsen T, Kilian M, et al.Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation[J]. J Clin Periodontol, 2006, 33(6):401-407.
[35] Savarrio L, Mackenzie D, Riggio M, et al.Detection of bacteraemias during non-surgical root canal treat-ment[J]. J Dent, 2005, 33(4):293-303.
[36] Daly CG, Mitchell DH, Highfield JE, et al.Bacteremia due to periodontal probing: a clinical and microbio-logical investigation[J]. J Periodontol, 2001, 72(2): 210-214.
[37] Tomás I, Alvarez M, Limeres J, et al.Prevalence, duration and aetiology of bacteraemia following dental extractions[J]. Oral Dis, 2007, 13(1):56-62.
[38] Lockhart PB, Bolger AF, Papapanou PN, et al.Perio- dontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Ass-ociation[J]. Circulation, 2012, 125(20):2520-2544.
[39] Bascones-Martinez A, Matesanz-Perez P, Escribano-Bermejo M, et al.Periodontal disease and diabetes-review of the literature[J]. Med Oral Patol Oral Cir Bucal, 2011, 16(6):e722-e729.
[40] Scannapieco FA.Role of oral bacteria in respiratory infection[J]. J Periodontol, 1999, 70(7):793-802.
[41] Poole S, Singhrao SK, Kesavalu L, et al.Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue[J]. J Alzheimers Dis, 2013, 36(4):665-677.
[42] Poole S, Singhrao SK, Chukkapalli S, et al.Active invasion of Porphyromonas gingivalis and infection-induced complement activation in ApoE-/- mice brainsns[J]. J Alzheimers Dis, 2015, 43(1):67-80.
[1] Fu Yu, He Wei, Huang Lan. Ferroptosis and its implication in oral diseases [J]. Int J Stomatol, 2024, 51(1): 36-44.
[2] Luo Xiaojie,Wang Dexu,Chen Xiaotao. Relationship between periodontitis and ferroptosis based on bioinformatics analysis [J]. Int J Stomatol, 2023, 50(6): 661-668.
[3] Huang Yuanhong,Peng Xian,Zhou Xuedong.. Progress in research into the effect of Rhizoma Drynariae on the treatment of bone-related diseases in the oral cavity [J]. Int J Stomatol, 2023, 50(6): 679-685.
[4] Hu Jia,Wang Xiuqing,Lu Guoying,Huang Xiaojing.. Regenerative endodontic procedures for permanent tooth with immature apices in adult patients [J]. Int J Stomatol, 2023, 50(6): 686-695.
[5] Gong Meiling,Cheng Xingqun,Wu Hongkun.. Research progress on the correlation between Parkinson’s disease and periodontitis [J]. Int J Stomatol, 2023, 50(5): 587-593.
[6] Xu Zhibo,Meng Xiuping.. Research progress on mechanism of Enterococcus faecalis escaping host immune defense [J]. Int J Stomatol, 2023, 50(5): 613-617.
[7] Sun Jia,Han Ye,Hou Jianxia. Research progress on the role of interleukin-6-hepcidin signal axis in regulating the pathogenesis of periodontitis-associated anemia [J]. Int J Stomatol, 2023, 50(3): 329-334.
[8] Liang Zhiying,Zhao Yuanxi,Zhu Jiani,Su Qin.. Retrospective analysis of clinical data of 288 cases of endodontic microsurgery on anterior teeth [J]. Int J Stomatol, 2023, 50(2): 166-171.
[9] Liu Tiqian,Liang Xing,Liu Weiqing,Li Xiaohong,Zhu Rui.. Research progress on the role and mechanism of occlusal trauma in the development of periodontitis [J]. Int J Stomatol, 2023, 50(1): 19-24.
[10] Li Qiong,Yu Weixian. Research progress on resveratrol for the treatment of periodontitis and its bioavailability [J]. Int J Stomatol, 2023, 50(1): 25-31.
[11] Cheng Yifan,Qin Xu,Jiang Ming,Zhu Guang-xun.. Research progress on innate lymphoid cells in periodontal diseases [J]. Int J Stomatol, 2023, 50(1): 32-36.
[12] Huang Weikun,Xu Qiuyan,Zhou Ting.. Role of baicalin and mechanisms through which baicalin attenuates oxidative stress injury induced by lipopolysaccharide on macrophages [J]. Int J Stomatol, 2022, 49(5): 521-528.
[13] Zhou Jianpeng,Xie Xudong,Zhao Lei,Wang Jun.. Research progress on the roles and mechanisms of T-helper 17 cells and interleukin-17 in periodontitis [J]. Int J Stomatol, 2022, 49(5): 586-592.
[14] Chen Huiyu,Bai Mingru,Ye Ling.. Progress in understanding the correlations between semaphorin 3A and common oral diseases [J]. Int J Stomatol, 2022, 49(5): 593-599.
[15] Zhou Jiajia,Zhao Lei,Xu Xin. Research progress on the genetic polymorphism of periodontitis [J]. Int J Stomatol, 2022, 49(4): 432-440.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 458 -460 .
[8] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 452 -454 .
[9] . [J]. Inter J Stomatol, 2008, 35(S1): .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .